Code
stringlengths 3
7
| Description
stringlengths 4
228
|
---|---|
T467X3D
|
Poisoning by peripheral vasodilators, assault, subsequent encounter
|
T467X3S
|
Poisoning by peripheral vasodilators, assault, sequela
|
T467X4A
|
Poisoning by peripheral vasodilators, undetermined, initial encounter
|
T467X4D
|
Poisoning by peripheral vasodilators, undetermined, subsequent encounter
|
T467X4S
|
Poisoning by peripheral vasodilators, undetermined, sequela
|
T467X5A
|
Adverse effect of peripheral vasodilators, initial encounter
|
T467X5D
|
Adverse effect of peripheral vasodilators, subsequent encounter
|
T467X5S
|
Adverse effect of peripheral vasodilators, sequela
|
T467X6A
|
Underdosing of peripheral vasodilators, initial encounter
|
T467X6D
|
Underdosing of peripheral vasodilators, subsequent encounter
|
T467X6S
|
Underdosing of peripheral vasodilators, sequela
|
T468X1A
|
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
|
T468X1D
|
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
|
T468X1S
|
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
|
T468X2A
|
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
|
T468X2D
|
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
|
T468X2S
|
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
|
T468X3A
|
Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
|
T468X3D
|
Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
|
T468X3S
|
Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela
|
T468X4A
|
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
|
T468X4D
|
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
|
T468X4S
|
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
|
T468X5A
|
Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
|
T468X5D
|
Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
|
T468X5S
|
Adverse effect of antivaricose drugs, including sclerosing agents, sequela
|
T468X6A
|
Underdosing of antivaricose drugs, including sclerosing agents, initial encounter
|
T468X6D
|
Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
|
T468X6S
|
Underdosing of antivaricose drugs, including sclerosing agents, sequela
|
T46901A
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
|
T46901D
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
|
T46901S
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
|
T46902A
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
|
T46902D
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
|
T46902S
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
|
T46903A
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
|
T46903D
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
|
T46903S
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
|
T46904A
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
|
T46904D
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
|
T46904S
|
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
|
T46905A
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
|
T46905D
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
|
T46905S
|
Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
|
T46906A
|
Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
|
T46906D
|
Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
|
T46906S
|
Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela
|
T46991A
|
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
|
T46991D
|
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
|
T46991S
|
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
|
T46992A
|
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
|
T46992D
|
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
|
T46992S
|
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela
|
T46993A
|
Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
|
T46993D
|
Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter
|
T46993S
|
Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela
|
T46994A
|
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
|
T46994D
|
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
|
T46994S
|
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela
|
T46995A
|
Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
|
T46995D
|
Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
|
T46995S
|
Adverse effect of other agents primarily affecting the cardiovascular system, sequela
|
T46996A
|
Underdosing of other agents primarily affecting the cardiovascular system, initial encounter
|
T46996D
|
Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
|
T46996S
|
Underdosing of other agents primarily affecting the cardiovascular system, sequela
|
T470X1A
|
Poisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter
|
T470X1D
|
Poisoning by histamine H2-receptor blockers, accidental (unintentional), subsequent encounter
|
T470X1S
|
Poisoning by histamine H2-receptor blockers, accidental (unintentional), sequela
|
T470X2A
|
Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter
|
T470X2D
|
Poisoning by histamine H2-receptor blockers, intentional self-harm, subsequent encounter
|
T470X2S
|
Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela
|
T470X3A
|
Poisoning by histamine H2-receptor blockers, assault, initial encounter
|
T470X3D
|
Poisoning by histamine H2-receptor blockers, assault, subsequent encounter
|
T470X3S
|
Poisoning by histamine H2-receptor blockers, assault, sequela
|
T470X4A
|
Poisoning by histamine H2-receptor blockers, undetermined, initial encounter
|
T470X4D
|
Poisoning by histamine H2-receptor blockers, undetermined, subsequent encounter
|
T470X4S
|
Poisoning by histamine H2-receptor blockers, undetermined, sequela
|
T470X5A
|
Adverse effect of histamine H2-receptor blockers, initial encounter
|
T470X5D
|
Adverse effect of histamine H2-receptor blockers, subsequent encounter
|
T470X5S
|
Adverse effect of histamine H2-receptor blockers, sequela
|
T470X6A
|
Underdosing of histamine H2-receptor blockers, initial encounter
|
T470X6D
|
Underdosing of histamine H2-receptor blockers, subsequent encounter
|
T470X6S
|
Underdosing of histamine H2-receptor blockers, sequela
|
T471X1A
|
Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter
|
T471X1D
|
Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), subsequent encounter
|
T471X1S
|
Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela
|
T471X2A
|
Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter
|
T471X2D
|
Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, subsequent encounter
|
T471X2S
|
Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela
|
T471X3A
|
Poisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter
|
T471X3D
|
Poisoning by other antacids and anti-gastric-secretion drugs, assault, subsequent encounter
|
T471X3S
|
Poisoning by other antacids and anti-gastric-secretion drugs, assault, sequela
|
T471X4A
|
Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter
|
T471X4D
|
Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, subsequent encounter
|
T471X4S
|
Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela
|
T471X5A
|
Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
|
T471X5D
|
Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
|
T471X5S
|
Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
|
T471X6A
|
Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter
|
T471X6D
|
Underdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter
|
Subsets and Splits
Diabetes Codes E10-E14
The query retrieves and sorts records with "Code" values between 'E10' and 'E14', offering a basic filter of the dataset but not providing significant analytical insights.